These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1426019)

  • 1. Marked decrease of A10 dopamine neuronal firing during ethanol withdrawal syndrome in rats.
    Diana M; Pistis M; Muntoni A; Rossetti ZL; Gessa G
    Eur J Pharmacol; 1992 Oct; 221(2-3):403-4. PubMed ID: 1426019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence.
    Diana M; Pistis M; Carboni S; Gessa GL; Rossetti ZL
    Proc Natl Acad Sci U S A; 1993 Sep; 90(17):7966-9. PubMed ID: 8367449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethanol withdrawal does not induce a reduction in the number of spontaneously active dopaminergic neurons in the mesolimbic system.
    Diana M; Pistis M; Muntoni AL; Gessa GL
    Brain Res; 1995 Jun; 682(1-2):29-34. PubMed ID: 7552323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonidine fails to modify dopaminergic neuronal activity during morphine withdrawal.
    Gobbi G; Muntoni AL; Gessa GL; Diana M
    Psychopharmacology (Berl); 2001 Oct; 158(1):1-6. PubMed ID: 11685378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal from intermittent ethanol exposure increases probability of burst firing in VTA neurons in vitro.
    Hopf FW; Martin M; Chen BT; Bowers MS; Mohamedi MM; Bonci A
    J Neurophysiol; 2007 Oct; 98(4):2297-310. PubMed ID: 17699688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats.
    Diana M; Pistis M; Muntoni A; Gessa G
    J Pharmacol Exp Ther; 1995 Feb; 272(2):781-5. PubMed ID: 7853194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesolimbic dopaminergic reduction outlasts ethanol withdrawal syndrome: evidence of protracted abstinence.
    Diana M; Pistis M; Muntoni A; Gessa G
    Neuroscience; 1996 Mar; 71(2):411-5. PubMed ID: 9053796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nimodipine on extracellular dopamine levels in the rat nucleus accumbens in ethanol withdrawal.
    Rossetti ZL; Isola D; De Vry J; Fadda F
    Neuropharmacology; 1999 Sep; 38(9):1361-9. PubMed ID: 10471090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acupuncture normalizes the release of accumbal dopamine during the withdrawal period and after the ethanol challenge in chronic ethanol-treated rats.
    Zhao RJ; Yoon SS; Lee BH; Kwon YK; Kim KJ; Shim I; Choi KH; Kim MR; Golden GT; Yang CH
    Neurosci Lett; 2006 Feb; 395(1):28-32. PubMed ID: 16289320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethanol withdrawal reduces the number of spontaneously active ventral tegmental area dopamine neurons in conscious animals.
    Shen RY
    J Pharmacol Exp Ther; 2003 Nov; 307(2):566-72. PubMed ID: 12966156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesolimbic dopaminergic decline after cannabinoid withdrawal.
    Diana M; Melis M; Muntoni AL; Gessa GL
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10269-73. PubMed ID: 9707636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine and serotonin release-regulating autoreceptor sensitivity in A9/A10 cell body and terminal areas after withdrawal of rats from continuous infusion of cocaine.
    Chen NH; Reith ME
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1445-53. PubMed ID: 8263807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In alcohol-treated rats, naloxone decreases extracellular dopamine and increases acetylcholine in the nucleus accumbens: evidence of opioid withdrawal.
    Rada P; Johnson DF; Lewis MJ; Hoebel BG
    Pharmacol Biochem Behav; 2004 Dec; 79(4):599-605. PubMed ID: 15582668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol withdrawal results in aberrant membrane properties and synaptic responses in periaqueductal gray neurons associated with seizure susceptibility.
    Yang L; Long C; Evans MS; Faingold C
    Brain Res; 2002 Dec; 957(1):99-108. PubMed ID: 12443985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 6-hydroxydopamine-induced lesions of A10 dopaminergic neurons and neuroleptic or bromocriptine treatment on ethanol withdrawal syndrome in rats.
    Trzaskowska E; Puciłowski O; Kostowski W; Bidziński A
    Pol J Pharmacol Pharm; 1983; 35(5):339-49. PubMed ID: 6141554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in repeated ethanol-withdrawal-induced anxiety-like behavior by site-selective injections of 5-HT1A and 5-HT2C ligands.
    Overstreet DH; Knapp DJ; Angel RA; Navarro M; Breese GR
    Psychopharmacology (Berl); 2006 Jul; 187(1):1-12. PubMed ID: 16767411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems.
    Gronier B; Debonnel G
    Eur J Pharmacol; 1999 Mar; 368(2-3):183-96. PubMed ID: 10193654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions.
    Zhang Y; Loonam TM; Noailles PA; Angulo JA
    Ann N Y Acad Sci; 2001 Jun; 937():93-120. PubMed ID: 11458542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol.
    Tanda G; Loddo P; Di Chiara G
    Eur J Pharmacol; 1999 Jul; 376(1-2):23-6. PubMed ID: 10440085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates DeltaFosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats.
    Wang HL; Xiang XH; Guo Y; Wu WR; Cao DY; Wang HS; Zhao Y
    Eur J Pharmacol; 2005 Dec; 527(1-3):94-104. PubMed ID: 16303124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.